Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
What Does Adjuvant Cancer Treatment Mean? Definitions, Uses, and Benefits
What Does Adjuvant Cancer Treatment Mean? Definitions, Uses, and Benefits 4

At Liv Hospital, we know how vital adjuvant therapy is in cancer care. Adjuvant treatment is extra help given after the main treatments. It aims to boost the overall effect and lower the chance of cancer coming back.

We add adjuvant therapies to main treatments like surgery or radiation. This helps get rid of any cancer cells left behind. It makes it less likely for cancer to come back, helping patients live longer.

Our team works together to give you the best care. We want you to know about the benefits and definitions of adjuvant therapy. It’s key to your recovery.

Key Takeaways

  • Adjuvant therapy is a supplementary treatment given after primary cancer treatment.
  • It aims to eliminate remaining cancer cells and reduce the risk of recurrence.
  • Adjuvant therapy can significantly improve long-term survival rates for various cancers.
  • Our team at Liv Hospital provides multidisciplinary, patient-centered care.
  • Understanding adjuvant therapy is vital for patients to make informed decisions about their care.

Adjuvant Cancer Treatment: Definition and Core Concepts

image 1149 LIV Hospital
What Does Adjuvant Cancer Treatment Mean? Definitions, Uses, and Benefits 5

Adjuvant cancer treatment is a key part of cancer care. It’s therapy given after the main treatment to lower cancer coming back.

The Fundamental Principles of Adjuvant Therapy

The main idea of adjuvant therapy is to get rid of any cancer cells left after the first treatment. This is because tiny cancer cells can stay in the body, even after the main treatment.

Key principles include:

  • Targeting microscopic disease to prevent recurrence
  • Using evidence-based treatments to maximize efficacy
  • Tailoring therapy to the individual patient’s risk profile

Timing: Understanding the “Adjuvant Setting”

The adjuvant setting is the time after the first treatment when more treatments are given. Starting adjuvant treatment early is key. It works best before any tiny cancer cells can grow or spread.

Treatment PhasePrimary GoalTypical Treatments
Primary TreatmentRemove or destroy the main tumorSurgery, Radiation, Chemotherapy
Adjuvant TreatmentEliminate remaining cancer cellsChemotherapy, Hormone Therapy, Targeted Therapy

Understanding adjuvant therapy’s basics and timing helps us see its importance in cancer care. Our aim is to create personalized, effective plans. These plans aim to improve patient outcomes and quality of life.

The Critical Purpose of Adjuvant Cancer Therapy

image 1150 LIV Hospital
What Does Adjuvant Cancer Treatment Mean? Definitions, Uses, and Benefits 6

Adjuvant therapy is a key part of cancer treatment. It aims to lower the chance of cancer coming back. After the main treatment, like surgery, it helps get rid of any cancer cells left behind.

Eliminating Microscopic Disease After Primary Treatment

Adjuvant cancer therapy targets tiny cancer cells left after main treatment. Even after surgery, small cancer cells can stay in the body. Adjuvant chemotherapy kills these cells, lowering the chance of cancer returning.

Research shows adjuvant therapy boosts survival rates for many cancers. For example, in breast cancer, it cuts down recurrence risk and boosts survival.

Preventing Cancer Recurrence and Metastasis

Adjuvant therapy also stops cancer from coming back and spreading. It kills microscopic disease, stopping cancer cells from moving to other parts of the body. This is key for cancers that easily spread, like some breast and lung cancers.

  • Adjuvant therapy reduces the risk of cancer recurrence.
  • It helps in preventing metastasis by targeting remaining cancer cells.
  • Adjuvant treatments, such as chemotherapy and radiation, are tailored to the specific needs of the patient.

Doctors say, “The goal of adjuvant therapy is to give patients the best chance of a cure by getting rid of any remaining cancer cells.” This shows how vital adjuvant therapy is in treating cancer.

“Adjuvant therapy has changed how we fight cancer, giving patients a much better chance of survival.”

— An Oncologist

How Adjuvant Treatment Differs from Other Cancer Therapies

Adjuvant cancer treatment plays a key role in care, but what sets it apart? We need to look at how it compares to other treatments.

Adjuvant treatment is given after the main treatment, like surgery. It aims to get rid of any cancer cells left behind. This helps lower the chance of cancer coming back. Other treatments might be given before or instead of the main treatment.

Adjuvant vs. Neoadjuvant Approaches

Adjuvant and neoadjuvant therapies are two different methods. Neoadjuvant chemotherapy is used before surgery to make tumors smaller. This makes them easier to remove. Adjuvant treatment, on the other hand, is given after surgery to kill any cancer cells left behind.

The main goal of neoadjuvant therapy is to help the main treatment work better. Adjuvant therapy’s goal is to stop cancer from coming back by getting rid of any remaining cancer cells.

Adjuvant vs. Palliative Treatment Goals

Adjuvant and palliative care also have different goals. Palliative care focuses on easing symptoms and improving life quality for those with advanced cancer. It’s not meant to cure the disease but to offer comfort and support.

For example, someone with early-stage breast cancer might get adjuvant chemotherapy to prevent cancer from coming back. But someone with advanced cancer might get palliative care to manage pain and symptoms. Knowing these differences helps in making the right treatment choices.

Here are some key points to remember:

  • Timing: Adjuvant treatment is given after primary treatment, while neoadjuvant treatment is given before.
  • Goals: Adjuvant therapy aims to prevent recurrence, whereas neoadjuvant therapy aims to make primary treatment more effective, and palliative care focuses on symptom management.
  • Application: Adjuvant treatment is used for patients with a high risk of recurrence, while palliative care is typically used for patients with advanced or metastatic disease.

For more information on cancer treatment, including adjuvant therapies.

f Adjuvant Cancer Treatments

Adjuvant cancer treatment aims to get rid of any cancer cells left after the main treatment. It’s key to lower the chance of cancer coming back and to help patients do better.

Systemic Adjuvant Therapies

Systemic adjuvant therapies target cancer cells all over the body. They are used when cancer might have spread from the original tumor. These include:

  • Chemotherapy: Drugs are used to kill cancer cells. It’s a common treatment for many cancers.
  • Hormone Therapy: For cancers that grow because of hormones, like some breast and prostate cancers, hormone therapy blocks these hormones. It helps lower the chance of cancer coming back.
  • Immunotherapy: This boosts the body’s immune system to fight cancer cells better.
  • Targeted Therapies: These treatments aim at specific parts of cancer cells, like proteins or genes. They stop cancer from growing and spreading.

Localized Adjuvant Treatments

Localized adjuvant treatments target cancer cells in a specific area. The main type is:

  • Radiation Therapy: High-energy rays are used to kill cancer cells in one area. This lowers the risk of cancer coming back in that area.

We pick treatments based on the cancer type, its stage, and the patient’s health. By mixing systemic and localized treatments, we create a plan that fits each patient’s needs.

Choosing between systemic and localized treatments depends on many things. It’s a complex decision that a team of healthcare experts makes together.

Adjuvant Chemotherapy: Applications and Protocols

Adjuvant chemotherapy is key in getting rid of cancer cells left after the first treatment. It’s a big part of cancer care and helps patients a lot.

Mechanism of Action

In the adjuvant setting, chemotherapy goes after tiny cancer cells left after surgery or radiation. Chemotherapy drugs mess with the DNA of cancer cells, stopping them from growing. This treatment can reach cancer cells in other parts of the body, helping prevent it from coming back.

Common Drug Regimens and Duration

The type of chemotherapy depends on the cancer, its stage, and the patient’s health. Here are some common ones:

  • AC-T (Adriamycin, Cyclophosphamide, followed by Taxotere) for breast cancer
  • FOLFOX (5-Fluorouracil, Leucovorin, Oxaliplatin) for colorectal cancer
  • BEP (Bleomycin, Etoposide, Platinum) for testicular cancer

Treatment lasts from 3 to 6 months, based on the plan and how the patient responds.

Patient Selection Criteria

Choosing who gets adjuvant chemotherapy involves looking at several things. Multidisciplinary tumor boards help decide the best treatment for each patient.

Important factors include:

  1. Cancer stage and grade
  2. Hormone receptor and HER2 status
  3. Patient’s overall health and preferences

Adjuvant chemotherapy is a key part of cancer care, giving patients a better chance of survival. Knowing how it works helps doctors create treatment plans that fit each patient’s needs.

Hormone Therapy as Adjuvant Treatment for Cancer

Hormone therapy has changed how we treat some cancers, like breast and prostate cancer. It’s used to stop cancer from coming back after surgery. This is because some cancers grow because of hormones in the body.

Breast Cancer Hormone Therapy Approaches

In breast cancer, hormone therapy is for tumors that need hormones to grow. The goal is to stop these hormones from reaching the cancer cells. This helps stop the cancer from growing.

There are a few ways to do this:

  • Selective estrogen receptor modulators (SERMs) like tamoxifen, which stop estrogen from helping the cancer grow.
  • Aromatase inhibitors (AIs) that lower estrogen levels by blocking the enzyme that makes it.

These treatments have been proven to lower the chance of cancer coming back in hormone-sensitive breast cancer patients.

Prostate Cancer Adjuvant Hormonal Treatments

In prostate cancer, hormone therapy is used to lower male hormones like testosterone. These hormones help prostate cancer grow.

There are a few ways to do this:

  • Gonadotropin-releasing hormone (GnRH) agonists or antagonists, which lower testosterone levels.
  • Anti-androgens that stop androgens from working on prostate cancer cells.
Therapy TypeMechanism of ActionCancer Type
SERMs (e.g., Tamoxifen)Blocks estrogen receptorsBreast Cancer
Aromatase InhibitorsLowers estrogen levelsBreast Cancer
GnRH Agonists/AntagonistsReduces testosterone productionProstate Cancer
Anti-androgensBlocks androgen actionProstate Cancer

Understanding hormone therapy’s role in treating cancer helps us see its importance. It’s key in helping patients with hormone-sensitive cancers.

Adjuvant Radiation Therapy: Techniques and Benefits

Modern cancer treatment often includes adjuvant radiation therapy. It targets microscopic disease left after primary treatment. This method is key in managing many cancers, improving patient outcomes by lowering local recurrence risk.

Modern Radiation Approaches After Surgery

Recent advances in radiation therapy have brought more precise and effective treatments. Techniques like intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT) allow for precise radiation delivery. This minimizes harm to healthy tissues around the tumor.

Key benefits of modern radiation approaches include:

  • Improved precision in targeting residual cancer cells
  • Reduced risk of damage to surrounding healthy tissues
  • Enhanced patient outcomes due to more effective treatment

Targeted Radiation to Prevent Local Recurrence

Adjuvant radiation therapy aims to remove microscopic cancer cells left after surgery. It targets the tumor bed and high-risk areas, lowering local recurrence chances.

As noted by cancer research experts, “The integration of adjuvant radiation therapy into cancer treatment protocols has been a major factor in improving survival rates and reducing recurrence.”

Our team at the cancer center uses advanced radiation therapy techniques for personalized care. We tailor treatment plans to meet each patient’s needs, aiming to improve outcomes and quality of life.

The role of adjuvant radiation therapy in oncology is vital. Understanding its methods and benefits helps patients and healthcare providers make informed treatment choices. This leads to better patient outcomes.

Emerging Adjuvant Treatments: Immunotherapy and Targeted Therapies

The field of adjuvant cancer treatment is changing with new treatments. Immunotherapy and targeted therapies are being studied to help the body fight cancer better. They aim to target specific parts of cancer cells and improve treatment results.

Checkpoint Inhibitors in the Adjuvant Setting

Checkpoint inhibitors are a new type of immunotherapy. They help the immune system fight cancer by blocking certain proteins. This makes it easier for the body to attack cancer cells.

Studies show these treatments can help prevent cancer from coming back. They are being tested in cancers like melanoma, lung cancer, and kidney cancer.

Targeted Molecular Therapies After Primary Treatment

Targeted molecular therapies are another new area in treatment. They focus on specific genetic changes in cancer cells. By targeting these changes, they can stop cancer from coming back.

In breast cancer, treatments targeting HER2-positive tumors have been very effective. This shows how important it is to match treatments to the specific cancer.

Combination Approaches for Enhanced Efficacy

Using different treatments together is a promising idea. For example, combining immunotherapy with other therapies might work better. Researchers are looking at different combinations to find the best ones.

It’s important to keep an eye on the side effects of these new treatments. More research is needed to make sure they are safe and effective. This will help us find better ways to treat cancer.

Cancer-Specific Adjuvant Treatment Approaches

Adjuvant cancer treatments vary by cancer type. Each cancer needs a unique treatment plan. The choice depends on the cancer type, stage, and biological traits. We’ll look at treatments for breast, colorectal, and lung cancers, focusing on new advancements and guidelines.

Breast Cancer Adjuvant Therapy Standards

Adjuvant therapy is key for early-stage breast cancer. It’s chosen based on tumor size, grade, hormone receptor status, and HER2 status.

  • Chemotherapy: Given to those with high-risk disease, before or after surgery.
  • Hormone Therapy: Used for hormone receptor-positive cancer to lower recurrence risk.
  • Targeted Therapy: HER2-positive patients get targeted therapies like trastuzumab.

Colorectal Cancer Adjuvant Protocols

Colorectal cancer treatment often includes chemotherapy, sometimes with radiation. This depends on the tumor’s stage and location.

  1. Stage III Disease: Adjuvant chemotherapy is standard for stage III colon cancer, using fluoropyrimidine-based regimens.
  2. Rectal Cancer: Treatment may include chemotherapy and radiation to lower local recurrence risk.

Studies are looking into targeted therapies for colorectal cancer, showing promising results.

Lung Cancer Adjuvant Treatment Advances

Lung cancer treatment has seen big changes. Chemotherapy is key for early-stage non-small cell lung cancer (NSCLC).

  • Chemotherapy: It improves survival for patients with resected NSCLC, mainly in stages II and III.
  • Targeted Therapy and Immunotherapy: New evidence supports their use in NSCLC, based on molecular profiling.

These developments mark a shift towards more personalized lung cancer treatment, leading to better patient outcomes.

The Multidisciplinary Approach to Adjuvant Treatment Planning

Creating personalized adjuvant treatment plans is key. It involves experts from oncology, surgery, pathology, and radiology. This ensures a complete care approach.

Tumor Board Recommendations and Personalized Plans

Tumor boards are vital in planning adjuvant treatments. They bring specialists together to review cases and make plans. Experts from different fields help tailor treatments for each patient.

These boards look at all angles to find the best treatments. This teamwork makes treatments more precise. It can lead to better results for patients.

Integrating Pathology and Molecular Testing

Pathology and molecular testing guide treatment choices. They give insights into the tumor’s genetic makeup. This helps doctors pick targeted therapies that work better.

Molecular tests show genetic changes that affect treatment response. Using this info, doctors can offer more personalized care. This care is likely to be more effective.

Evidence-Based Benefits of Adjuvant Cancer Treatment

Adjuvant therapy in cancer treatment offers many benefits. It improves survival rates and quality of life. It’s a key part of cancer care, helping patients across different types of cancer.

Survival Rate Improvements Across Cancer Types

Adjuvant therapy boosts survival rates for various cancers. It gets rid of tiny cancer cells left after primary treatment. This lowers the chance of cancer coming back.

In breast cancer, treatments like chemotherapy and hormone therapy have greatly improved survival. For colorectal cancer, chemotherapy is now a standard to prevent cancer from coming back. Learn more about first-line treatments for oncology and how adjuvant therapy fits into them.

Research shows adjuvant therapy significantly improves survival and disease-free rates. For example, in breast cancer, chemotherapy cuts recurrence risk by up to 30%. This highlights adjuvant therapy’s role in modern cancer care.

Quality of Life Considerations and Supportive Care

Adjuvant therapy is key for survival but also affects quality of life. It can cause side effects that impact physical and emotional health. Supportive care is vital to manage these effects and improve life quality.

A team approach to care is essential. It includes specialized services like pain management, nutrition support, and counseling. This approach helps reduce therapy’s negative effects and improves outcomes.

Balancing Benefits Against Side Effects

One big challenge is weighing therapy benefits against side effects. Adjuvant therapy aims to prevent cancer return but can be toxic. It’s important to consider each patient’s unique situation.

We tailor treatment plans to each patient. This considers cancer type, stage, and overall health. This approach maximizes therapy’s benefits while reducing harm, improving life quality and outcomes.

Conclusion: The Future of Adjuvant Therapy in Modern Oncology

Understanding adjuvant cancer treatment is key in modern oncology. It has changed cancer treatment by lowering recurrence rates and improving survival. Research is ongoing to make adjuvant therapies better and to find new treatments like immunotherapy and targeted therapies.

New trends in adjuvant therapy are making patient outcomes better. We’re seeing big steps forward in treatments for cancers like breast, colorectal, and lung. Molecular testing and personalized plans are becoming more important in treatment planning.

Adjuvant therapy will keep being a big part of cancer treatment. It gives patients the best chance for long-term survival and a good quality of life. Healthcare providers can offer the best care by keeping up with these advances.

What is adjuvant cancer treatment?

Adjuvant cancer treatment is given after main treatments like surgery or radiation. It aims to get rid of any cancer cells left behind. This helps lower the chance of cancer coming back.

What is the purpose of adjuvant therapy?

The main goal of adjuvant therapy is to kill off tiny cancer cells left after main treatments. This stops cancer from coming back and spreading.

How does adjuvant treatment differ from neoadjuvant treatment?

Adjuvant treatment comes after main treatments. Neoadjuvant treatment is given before to shrink tumors. This makes them easier to remove surgically.

What are the major types of adjuvant cancer treatments?

Main types include systemic treatments like chemotherapy, hormone therapy, and immunotherapy. Localized treatments like radiation therapy are also used.

How is adjuvant chemotherapy used in cancer treatment?

Adjuvant chemotherapy targets and kills cancer cells left in the body. It lowers the risk of cancer coming back in many types of cancer.

What is the role of hormone therapy in adjuvant cancer treatment?

Hormone therapy is used for hormone-sensitive cancers like breast and prostate cancer. It blocks or lowers hormone production to reduce recurrence risk.

How does adjuvant radiation therapy work?

Adjuvant radiation therapy targets areas where cancer might come back. It kills off remaining cancer cells and lowers local recurrence risk.

What are emerging trends in adjuvant cancer treatment?

New trends include using immunotherapy, targeted therapies, and combining treatments. These aim to boost immune responses and improve outcomes.

How is adjuvant treatment planned and personalized?

Treatment planning involves a team approach, including tumor boards. It uses pathology and molecular testing to create personalized plans.

What are the benefits of adjuvant cancer treatment?

Benefits include better survival rates, lower recurrence risk, and improved quality of life. These apply to various cancer types.

What is the importance of considering quality of life in adjuvant treatment?

Quality of life is key in adjuvant treatment. It helps manage therapy side effects and provides supportive care. This ensures a good balance between benefits and side effects.

How does adjuvant therapy impact cancer recurrence and metastasis?

Adjuvant therapy prevents recurrence and metastasis by killing off microscopic disease. This improves patient outcomes significantly.

References

Wikipedia: Adjuvant therapy

PubMed Central (NCBI): Predictive and Prognostic Biomarkers for Adjuvant Therapy in Cancer

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 26 75